 |
Pheon Therapeutics
Last updated: August 22, 2024
CEO Bertrand Damour
UK | Funding: $188M (+)
Website: https://pheontx.com
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
Website: https://pheontx.com
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
